Story thread · 2 reports / 2 sources
Helus Pharma Reports First Quarter Fiscal 2027 Financial Results and Recent Business Highlights
thestar.com · 2h · first report
- Appointed Michael Halstead, former President of Intra-Cellular Therapies, as Chief Executive Officer to lead Helus Pharma through late-stage development and commercialization -
The conversation · 0
Sign in to join the conversation.
No comments yet — start the thread.